Again, such frequencies were consistent with those reported in literature (ranging from 12% to 19% for CyclinD1 amplification [27,42-44] and calculated in about 7% of all cutaneous melanomas for cKIT amplification [25,31]). This evidence concerns the gene CCND1 and cutaneous melanoma.